Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Vivos Therapeutics (VVOS) Interest Coverage Ratio (2020 - 2022)

Vivos Therapeutics has reported Interest Coverage Ratio over the past 3 years, most recently at 150.19 for Q3 2022.

  • Quarterly Interest Coverage Ratio rose 75.44% to 150.19 in Q3 2022 from the year-ago period, while the trailing twelve-month figure was 583.11 through Jun 2023, down 393.59% year-over-year, with the annual reading at 304.36 for FY2021, 142.68% down from the prior year.
  • Interest Coverage Ratio was 150.19 for Q3 2022 at Vivos Therapeutics, up from 188.22 in the prior quarter.
  • Over five years, Interest Coverage Ratio peaked at 2177.5 in Q4 2021 and troughed at 4061.0 in Q2 2021.
  • The 3-year median for Interest Coverage Ratio is 174.71 (2022), against an average of 638.26.
  • The largest YoY upside for Interest Coverage Ratio was 700.09% in 2021 against a maximum downside of 5722.38% in 2021.
  • A 3-year view of Interest Coverage Ratio shows it stood at 362.86 in 2020, then soared by 700.09% to 2177.5 in 2021, then tumbled by 106.9% to 150.19 in 2022.
  • Per Business Quant, the three most recent readings for VVOS's Interest Coverage Ratio are 150.19 (Q3 2022), 188.22 (Q2 2022), and 174.71 (Q1 2022).